Greatbatch Inc  

(Public, NYSE:GB)   Watch this stock  
Find more results for GB
-0.39 (-1.05%)
Feb 5 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 36.46 - 37.72
52 week 35.77 - 63.19
Open 36.91
Vol / Avg. 501,029.00/281,477.00
Mkt cap 1.12B
P/E 30.56
Div/yield     -
EPS 1.20
Shares 30.56M
Beta 1.33
Inst. own 93%
Feb 22, 2016
Q4 2015 Greatbatch Inc Earnings Release (Estimated) - 4:00PM EST - Add to calendar
Jan 11, 2016
Greatbatch Inc at JPMorgan Healthcare Conference - Meetings
Nov 11, 2015
Greatbatch Inc at Credit Suisse Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q4 (Oct '15) 2015
Net profit margin 0.01% 8.06%
Operating margin 0.81% 11.00%
EBITD margin - 16.85%
Return on average assets 0.01% 6.01%
Return on average equity 0.01% 9.60%
Employees 3,690 -
CDP Score - -


2591 Dallas Pkwy Ste 101
FRISCO, TX 75034-8543
United States - Map
+1-716-7595600 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Greatbatch, Inc. is a developer and manufacturer of medical devices and components. The Company operates through two segments: Greatbatch Medical and QiG Group (QiG). Greatbatch Medical designs and manufactures products where the Company either owns the intellectual property or has unique manufacturing and assembly expertise. Greatbatch Medical's products include medical devices and components for the cardiac, neuromodulation, orthopedics, portable medical, vascular and energy markets. QiG focuses on developing medical device systems for some of healthcare's challenges and reflects the Company's strategic evolution of its product offerings in order to raise the growth and profitability profile of the Company. QiG utilizes a diversified portfolio approach with three investment modes: new medical device systems commercialization, collaborative programs with OEM customers and strategic equity positions in emerging healthcare companies.

Officers and directors

Bill R. Sanford Independent Chairman of the Board
Age: 71
Bio & Compensation  - Reuters
Thomas J. Hook President, Chief Executive Officer, Director
Age: 52
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Michael Dinkins Chief Financial Officer, Executive Vice President
Age: 60
Bio & Compensation  - Reuters
Andrew P. Holman Executive Vice President - Global Sales & Marketing
Age: 47
Bio & Compensation  - Reuters
Mauricio arellano Executive Vice President - Global Operations
Age: 48
Bio & Compensation  - Reuters
Thomas K. Hickman Executive Vice President, Global Sales & Marketing
Age: 49
Bio & Compensation  - Reuters
George M. Cintra Senior Vice President, Chief Technology Officer
Age: 53
Bio & Compensation  - Reuters
Timothy G. McEvoy Senior Vice President, General Counsel, Secretary
Age: 57
Bio & Compensation  - Reuters
Jean M. Hobby Director
Bio & Compensation  - Reuters
Martin Craig Maxwell Director
Age: 57
Bio & Compensation  - Reuters